Research has shown that varenicline tartrate - a novel new drug specifically developed for smoking cessation - allows smokers to abstain from cigarettes significantly longer and more effectively than smokers using a placebo. A paper in Respirology, published by Wiley-Blackwell, compared the efficacy of a standard 12-week regimen of varenicline for smoking cessation with a placebo on 333 subjects in 15 test sites across China, Singapore and Thailand.
(more...)